Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Retinol may affect immune responses in people with frequent skin boils.

Platelet-released growth factors can reduce inflammation in joint disease.

iNKT cells help develop and maintain healthy skin in young mice.

JAK inhibitors might help treat alopecia areata.

Inflammation is linked to hair loss.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

BMS-470539 reduces skin fibrosis and inflammation.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Cow milk sugars increase fat production and inflammation in skin oil cells.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

A patient developed a blister at the injection site after hepatitis C treatment.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.